1. Orphan Drug Use in Patients With Rare Diseases: A Population-Based Cohort Study
   Francesca Gorini et al, 2022, Frontiers in Pharmacology CrossRef
2. Kinetics and Mechanism of Oxidation of d-Penicillamine in Acidified Bromate and Aqueous Bromine
   Kudzanai Chipiso et al, 2016, Australian Journal of Chemistry CrossRef
3. Relapse following withdrawal of D‐penicillamine from combination (D‐penicillamine + zinc) therapy in hepatic Wilson disease
   Kalpana Panda et al, 2024, Journal of Pediatric Gastroenterology and Nutrition CrossRef
4. Emerging Roles of the Copper–CTR1 Axis in Tumorigenesis
   Yaqing Su et al, 2022, Molecular Cancer Research CrossRef
5. Early neurological deterioration in Wilson’s disease: a systematic literature review and meta-analysis
   Agnieszka Antos et al, 2023, Neurological Sciences CrossRef
6. DPM-1001 decreased copper levels and ameliorated deficits in a mouse model of Wilson's disease
   Navasona Krishnan et al, 2018, Genes & Development CrossRef
7. Monoisoamyl DMSA reduced copper-induced neurotoxicity by lowering 8-OHdG level, amyloid beta and Tau protein expressions in Sprague-Dawley rats
   Jayant Patwa et al, 2020, Metallomics CrossRef
8. Functional analysis and drug response to zinc and D-penicillamine in stableATP7Bmutant hepatic cell lines
   Gursimran Chandhok et al, 2016, World Journal of Gastroenterology CrossRef
9. Disorders of Mineralization
   Marie B. Demay et al, 2016, Endocrinology: Adult and Pediatric CrossRef
10. Clinical efficacy and safety of Gandouling plus low-dose D-penicillamine for treatment of Wilson's disease with neurological symptoms
    Zhang Jing et al, 2018, Journal of Traditional Chinese Medicine CrossRef
11. Anemia following zinc treatment for Wilson’s disease: a case report and literature review
    Sha Cai et al, 2019, BMC Gastroenterology CrossRef
12. Metal Antagonists
    Joshua P. Gray et al, 2014, A worldwide yearly survey of new data in adverse drug reactions CrossRef
13. Wilson disease
    Joseph Jankovic et al, 2021, Principles and Practice of Movement Disorders CrossRef
14. Adverse Events with d-penicillamine Therapy in Hepatic Wilson’s Disease: A Single-Center Retrospective Audit
    Sanjay Kumar et al, 2022, Clinical Drug Investigation CrossRef
15. Neurometabolische und neurodegenerative Krankheiten
    Jutta Gärtner et al, 2014, Neuropädiatrie CrossRef
16. The six metal binding domains in human copper transporter, ATP7B: molecular biophysics and disease-causing mutations
    Candan Ariöz et al, 2017, BioMetals CrossRef
17. Effectiveness of Low Dose D-Penicillamine Therapy in Neurologic Wilson Disease - A Prospective Observational Study
    Gopen Kumar Kundu et al, 2023, European Journal of Medical and Health Research CrossRef